About Us
TICKR provides access to alternative data for making informed investment decisions. Founded by OZMOSI, a leading healthcare data company, we offer data, insights, and tools for informed healthcare investment decisions at every level. Our mission is to equip investors with the knowledge and data they need to make smarter, more profitable choices.
OZMOSI brings a rich background in predictive analytics, risk assessments, and valuation models for the pharmaceutical industry to every project. Our founder, Beau Bush, has over 15 years of experience developing data-based business and investment strategies. His expertise includes preparing and delivering senior-level summaries and recommendations for global investment and growth strategies.
Experience-Driven Results
With the emergence of new business models and the increasing complexity of drug development, predicting the impact of new products and deciding which products to pursue has become more challenging. Beau created OZMOSI to bring clarity and confidence to investment decisions, shaping the future of pharma and biopharma products.
Empowering Data-Driven Decisions
At TICKR, we leverage OZMOSI’s extensive experience and expertise to deliver unparalleled insights to our users. Our platform is designed to help investors navigate the complexities of the market, providing clarity through alternative data. Whether you are monitoring critical dates for companies or analyzing market trends, TICKR equips you with the tools to make data-driven decisions and achieve higher returns. Join us and discover the advantage of informed investing with TICKR.
